|
01/06/2011 |
Ad hoc: MorphoSys to Start Share Buy-Back Program |
 |
|
21/01/2011 |
Ad hoc: MorphoSys Reports Preliminary, Unaudited Financial Results |
|
|
10/12/2010 |
Ad hoc: MorphoSys Increases Revenues and Operating Profit Guidance for 2010 |
|
|
07/10/2010 |
Ad hoc correction: MorphoSys Announces Acquisition of Sloning |
|
|
07/10/2010 |
Ad hoc: MorphoSys Announces Acquisition of Sloning |
|
|
27/06/2010 |
Ad hoc: MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program |
|
|
02/12/2007 |
Ad hoc: 1-MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Therapeutic Antibody Pipeline |
|
|
02/12/2007 |
Ad hoc: 2-MorphoSys Financial Guidance 2007 Under Review |
|
|
03/05/2007 |
Ad hoc: MorphoSys Reports Completion of Equity Issue |
|
|
02/05/2007 |
Ad hoc: MorphoSys Launches Share Capital Issuance |
|
|
26/03/2007 |
Ad hoc: MorphoSys Announces Change in Supervisory Board - Supervisory Board Nominates Walter Blättler as Successor of Andreas Plückthun |
|
|
27/07/2006 |
Hugin Ad hoc announcement according to § 15 WpHG: Pure forecast: MorphoSys AG: MorphoSys Raises Financial Guidance for 2006 |
|
